Effects of sazetidine-A, a selective α4β2 nicotinic acetylcholine receptor desensitizing agent on alcohol and nicotine self-administration in selectively bred alcohol-preferring (P) rats

[11] Blomqvist O(1998)Voluntary ethanol intake in the rat and the associated accumbal dopamine overflow are blocked by ventral tegmental mecamylamine Eur J Pharmcol 358 189-196

[12] Engel JA(2009)The smoking cessation medication varenicline attenuates alcohol and nicotine interactions in the rat mesolimbic dopamine system J Pharma Exp Ther 329 225-230

[13] Nissbrandt H(2009)Effects of mecamylamine on alcohol consumption and preference in male C57BL/6J mice Pharmacology 83 379-384

[14] Soderpalm B(1994)The effectiveness of the nicotine patch for smoking cessation—a meta-analysis JAMA 271 1940-1947

[15] Blomqvist O(2007)Exacerbation of schizophrenia by varenicline Am J Psychiat 164 169-23

[16] Ericson M(2009)The state of pharmacotherapy for the treatment of alcohol dependence J Subst Abuse Treat 36 15-308

[17] Johnson DH(1993)P and NP rats respond differently to the discriminative stimulus effects of nicotine Pharmacol Biochem Behav 45 305-322

[18] Engel JA(2006)Why do young women smoke? I. Direct and interactive effects of environment, psychological characteristics and nicotinic cholinergic receptor genes Mol Psychiatry 11 312-572

[19] Soderpalm B(2009)Modulation of ethanol drinking-in-the-dark by mecamylamine and nicotinic acetylcholine receptor agonists in C57BL/6J mice Psychopharmacology 204 563-63

[20] Brody AL(2006)Efficacy of varenicline, an alpha4beta2 nicotinic acetylcholine receptor partial agonist, vs placebo or sustained-release bupropion for smoking cessation: a randomized controlled trial JAMA 296 56-387

[11] Blomqvist O(1998)Voluntary ethanol intake in the rat and the associated accumbal dopamine overflow are blocked by ventral tegmental mecamylamine Eur J Pharmcol 358 189-196

[12] Engel JA(2009)The smoking cessation medication varenicline attenuates alcohol and nicotine interactions in the rat mesolimbic dopamine system J Pharma Exp Ther 329 225-230

[13] Nissbrandt H(2009)Effects of mecamylamine on alcohol consumption and preference in male C57BL/6J mice Pharmacology 83 379-384

[14] Soderpalm B(1994)The effectiveness of the nicotine patch for smoking cessation—a meta-analysis JAMA 271 1940-1947

[15] Blomqvist O(2007)Exacerbation of schizophrenia by varenicline Am J Psychiat 164 169-23

[16] Ericson M(2009)The state of pharmacotherapy for the treatment of alcohol dependence J Subst Abuse Treat 36 15-308

[17] Johnson DH(1993)P and NP rats respond differently to the discriminative stimulus effects of nicotine Pharmacol Biochem Behav 45 305-322

[18] Engel JA(2006)Why do young women smoke? I. Direct and interactive effects of environment, psychological characteristics and nicotinic cholinergic receptor genes Mol Psychiatry 11 312-572

[19] Soderpalm B(2009)Modulation of ethanol drinking-in-the-dark by mecamylamine and nicotinic acetylcholine receptor agonists in C57BL/6J mice Psychopharmacology 204 563-63

[20] Brody AL(2006)Efficacy of varenicline, an alpha4beta2 nicotinic acetylcholine receptor partial agonist, vs placebo or sustained-release bupropion for smoking cessation: a randomized controlled trial JAMA 296 56-387